1 | stage | 19,239 |
2 | astragaloside | 59 |
3 | coxa | 11 |
4 | pretext | 10 |
5 | baveno | 8 |
6 | ficat | 8 |
7 | risers | 7 |
8 | isopraeroside | 6 |
9 | dsm- | 5 |
10 | stage-5 | 5 |
11 | atp-ncep | 3 |
12 | confluences | 3 |
13 | non-bulky | 3 |
14 | sanders-type | 3 |
15 | swope | 3 |
16 | zoeae | 3 |
17 | 28-deglucosylchikusetsusaponin | 2 |
18 | manujet | 2 |
19 | naida | 2 |
20 | opening/closing | 2 |
21 | pasadena | 2 |
22 | sympathoactivation | 2 |
23 | tetraamine | 2 |
24 | 2/sln | 1 |
25 | anglo-celtic | 1 |
26 | belsey-mark | 1 |
27 | disease/no | 1 |
28 | dq-collagen | 1 |
29 | filcon | 1 |
30 | formation-metazoan | 1 |
31 | frgc | 1 |
32 | glycation-related | 1 |
33 | l'expiration | 1 |
34 | lph® | 1 |
35 | metastatic/progressing | 1 |
36 | outcomes/decreased | 1 |
37 | outcomes/increased | 1 |
38 | pedigerous | 1 |
39 | phosphodiesterase- | 1 |
40 | pn0-1mi | 1 |
41 | pressurometer | 1 |
42 | primary-stage | 1 |
43 | procollagenase | 1 |
44 | product-mediated | 1 |
45 | rarasaponins | 1 |
46 | rasrm | 1 |
47 | single-alternating | 1 |
48 | sort-out | 1 |
49 | success-post | 1 |
1 | 2/sln | 1 |
2 | 28-deglucosylchikusetsusaponin | 2 |
3 | anglo-celtic | 1 |
4 | astragaloside | 59 |
5 | atp-ncep | 3 |
6 | baveno | 8 |
7 | belsey-mark | 1 |
8 | confluences | 3 |
9 | coxa | 11 |
10 | disease/no | 1 |
11 | dq-collagen | 1 |
12 | dsm- | 5 |
13 | ficat | 8 |
14 | filcon | 1 |
15 | formation-metazoan | 1 |
16 | frgc | 1 |
17 | glycation-related | 1 |
18 | isopraeroside | 6 |
19 | l'expiration | 1 |
20 | lph® | 1 |
21 | manujet | 2 |
22 | metastatic/progressing | 1 |
23 | naida | 2 |
24 | non-bulky | 3 |
25 | opening/closing | 2 |
26 | outcomes/decreased | 1 |
27 | outcomes/increased | 1 |
28 | pasadena | 2 |
29 | pedigerous | 1 |
30 | phosphodiesterase- | 1 |
31 | pn0-1mi | 1 |
32 | pressurometer | 1 |
33 | pretext | 10 |
34 | primary-stage | 1 |
35 | procollagenase | 1 |
36 | product-mediated | 1 |
37 | rarasaponins | 1 |
38 | rasrm | 1 |
39 | risers | 7 |
40 | sanders-type | 3 |
41 | single-alternating | 1 |
42 | sort-out | 1 |
43 | stage | 19,239 |
44 | stage-5 | 5 |
45 | success-post | 1 |
46 | swope | 3 |
47 | sympathoactivation | 2 |
48 | tetraamine | 2 |
49 | zoeae | 3 |
1 | phosphodiesterase- | 1 |
2 | dsm- | 5 |
3 | stage-5 | 5 |
4 | naida | 2 |
5 | pasadena | 2 |
6 | coxa | 11 |
7 | frgc | 1 |
8 | anglo-celtic | 1 |
9 | outcomes/decreased | 1 |
10 | outcomes/increased | 1 |
11 | product-mediated | 1 |
12 | glycation-related | 1 |
13 | zoeae | 3 |
14 | astragaloside | 59 |
15 | isopraeroside | 6 |
16 | stage | 19,239 |
17 | primary-stage | 1 |
18 | tetraamine | 2 |
19 | swope | 3 |
20 | sanders-type | 3 |
21 | procollagenase | 1 |
22 | opening/closing | 2 |
23 | metastatic/progressing | 1 |
24 | single-alternating | 1 |
25 | pn0-1mi | 1 |
26 | belsey-mark | 1 |
27 | rasrm | 1 |
28 | formation-metazoan | 1 |
29 | dq-collagen | 1 |
30 | 28-deglucosylchikusetsusaponin | 2 |
31 | 2/sln | 1 |
32 | filcon | 1 |
33 | l'expiration | 1 |
34 | sympathoactivation | 2 |
35 | disease/no | 1 |
36 | baveno | 8 |
37 | atp-ncep | 3 |
38 | pressurometer | 1 |
39 | confluences | 3 |
40 | rarasaponins | 1 |
41 | risers | 7 |
42 | pedigerous | 1 |
43 | ficat | 8 |
44 | manujet | 2 |
45 | success-post | 1 |
46 | sort-out | 1 |
47 | pretext | 10 |
48 | non-bulky | 3 |
49 | lph® | 1 |